This week's Fierce Pharma is brought to you by Sophia Genetics.

Webinar: Addressing Global Inequalities in Comprehensive Cancer Care

Thursday, September 5, 2024 / 12:00pm ET | 9:00am PT

Liquid biopsy is emerging as a revolutionary technology, offering swift and precise diagnostics. It has the potential to significantly impact precision oncology by providing a non-invasive approach for cancer detection, monitoring, and treatment selection. However, liquid biopsy still faces challenges, including workflow standardization and broad adoption across the globe.

• Transforming Cancer Care with MSK-ACCESS® powered with SOPHiA DDM™
• Closing the Gap: Reducing Inequalities in Global Cancer Care
• Strategic Alliances for Healthcare Innovation: Lessons from SOPHiA GENETICS, MSK, and AstraZeneca

Key topics include: